MedPath

A CLINICAL STUDY TO ASSESS THE EFFICACY OF SHATYADI CHURNA WITH ERANDBHRUSTA HARITAKI CHURNA AND WITHOUT ERANDBHRUSTA HARITAKI CHURNA AS ANULOMAN IN TAMAK SHWASA (BRONCHIAL ASTHMA)

Recruiting
Conditions
TAMAK SHWASA (BRONCHIAL ASTHMA)
Registration Number
CTRI/2017/07/009051
Lead Sponsor
GOVT AKHANDANAND AYURVEDIC COLLEGE AND HOSPITAL AHMEDABAD AND MANIBEN AYURVED HOSPITAL AHMEDABAD
Brief Summary

This is a randomized parallel group trial in department of Kayachikitsa OPD at Government Akhandanand Ayurvedic college and hospital and Maniben Ayurved hospital,Ahmedabad Gujarat.

Dealing with the treatment of disease Tamak Shwasa(Bronchial Asthma) ,Acharya Charak has mentioned that it should be treated with the drugs having properties like kaphashamak ,vatashamak, ushna and vatanuloman.This both the drugs are ushna and kaphavatashamak.In addition Erandbhrusta haritaki is vatanuloman drug.Therefore in this study,Shatyadi churna and Erandbhrusta haritaki churna have been selected for clinical trial.

This study is trial to evaluate the efficacy of Shatyadi churna in a Dose of 3 gms 4 times in a day in empty stomach with lukewarm water and Duration of 4 weeks along with  Erandbhrusta haritaki churna in a Dose of 2 gms 2 times in a day before meal with lukewarm water and Duration of 4 weeks in 15 patients in GROUP A and only Shatyadi churna with same Dose and Duration as given in group A, in 15 patients with GROUP B in Bronchial Asthma.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients present with classical sign & symptoms of Tamak shwasa like Shwasakastata(Breathlessness), Ativege Kasate(Frequent bouts of coughing), Ghurghurukam(wheezing), Peenasa(Coryza), Asino Labhate Saukhyam(Comfort in sitting posture), Lalate Sweda, Vishushkashyata(Dryness of mouth).

Exclusion Criteria

Asthma due to cardiac origin Pathologic conditions like Tuberculosis,Cor pulmonale,Emphysema,malignancy,tumour Patients having disease like Hypertension,Diabetes Mellitus,severe Anaemia Patients with severity of more than 2 attacks per day.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Shwasakastata(Breathlessness),Ativege Kasa(Frequent bouts of coughing),Ghurghurukam (Wheezing),Peenasa(Coryza), Asino Labhate Saukhyam(Comfort in sitting posture),Dryness of mouth,P.E.F.R4 WEEKS
Secondary Outcome Measures
NameTimeMethod
Shwasakastata(Breathlessness),Ativege Kasa(Frequent bouts of coughing),Ghurghurukam (Wheezing),Peenasa(Coryza), Asino Labhate Saukhyam(Comfort in sitting posture),Dryness of mouth,P.E.F.R4 WEEKS

Trial Locations

Locations (1)

GOVT AKHANDANAND AYURVEDIC COLLEGE

🇮🇳

Ahmadabad, GUJARAT, India

GOVT AKHANDANAND AYURVEDIC COLLEGE
🇮🇳Ahmadabad, GUJARAT, India
NISHA M PRAJAPATI
Principal investigator
9016275596
drnisha.1711@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.